• HyperScript RT SuperMix for qPCR: Unlocking Robust cDNA Synt

  2026-05-25

  HyperScript™ RT SuperMix for qPCR empowers researchers to tackle gene expression analysis even with low-concentration or structurally complex RNA samples, thanks to its engineered thermostable reverse transcriptase and optimized primer blend. This solution streamlines challenging workflows, ensuring reproducible and accurate results—especially vital in translational models such as diabetic foot ulcer healing.

• Lipid Nanoparticle Delivery of B7H3-BiTE mRNA for Tumor Immu

  2026-05-25

  A recent study demonstrates that encapsulating mRNA encoding a B7H3×CD3 bispecific antibody within lipid nanoparticles (LNPs) can induce potent and durable antitumor effects in mouse models of malignancy. This approach overcomes key limitations of traditional BiTE protein therapeutics and highlights the clinical promise of mRNA-based antibody expression systems.

• HotStart™ 2X Green qPCR Master Mix: Mechanism & Benchmarks

  2026-05-24

  HotStart™ 2X Green qPCR Master Mix (K1070) enables high-specificity and reproducible SYBR Green-based qPCR workflows. Its antibody-mediated hot-start Taq polymerase inhibition and robust SYBR Green chemistry minimize non-specific amplification, supporting reliable gene expression analysis and nucleic acid quantification. This article details its mechanism, peer-reviewed evidence, and workflow integration.

• IPA-3: Selective Pak1 Inhibitor for Kinase Pathway Research

  2026-05-23

  IPA-3 (1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol) is a selective, non-ATP competitive inhibitor of Pak1, enabling precise modulation of kinase pathways. It demonstrates high selectivity by targeting the autoregulatory domain rather than the ATP-binding site, supporting studies in cancer biology, neuroinflammation, and kinase activity assays. Peer-reviewed and product data confirm its reproducibility and specificity.

• Verbascoside: Applied Workflows for PKC/NF-κB Inhibition in

  2026-05-22

  Verbascoside offers reproducible, high-purity PKC/NF-κB pathway inhibition, enabling precise control of osteoclastogenesis and inflammatory signaling. Discover how APExBIO’s Verbascoside streamlines complex experimental workflows, addresses common troubleshooting hurdles, and bridges the latest molecular findings with practical lab protocols.

• Perphenazine: Dopamine D2 Receptor Antagonist in Applied Res

  2026-05-22

  Perphenazine stands out as a multifaceted dopamine D2 receptor antagonist, enabling both neuropharmacology and host-directed antibacterial research. Recent mechanistic findings and optimized workflows position APExBIO’s Perphenazine as a benchmark tool for researchers seeking robust, reproducible outcomes in cell death, opioid tolerance, and macrophage activation assays.

• TaqI Restriction Endonuclease: Rapid DNA Cleavage for Resear

  2026-05-21

  TaqI Restriction Endonuclease (SKU K3053) delivers rapid, sequence-specific cleavage of plasmid, PCR, or genomic DNA, addressing the need for fast and reproducible DNA digestion in molecular biology workflows. It is not intended for diagnostic or clinical use and is best suited for standard DNA substrates requiring sticky ends for downstream cloning or analysis.

• Molecular Mechanisms of Fruit Abscission in Actinidia arguta

  2026-05-21

  This study identifies the hormonal and transcriptional networks driving physiological fruit abscission in Actinidia arguta. Using comparative transcriptomics and gene overexpression, the research uncovers critical hormone crosstalk and cell wall remodeling pathways, providing a foundation for targeted breeding to reduce fruit loss.

• NBC19: Potent NLRP3 Inflammasome Inhibitor for Inflammation

  2026-05-20

  NBC19 is a nanomolar-potency NLRP3 inflammasome inhibitor that precisely suppresses IL-1β release in cellular models. It enables targeted investigation of inflammasome-driven inflammation, with validated efficacy in Nigericin- and ATP-induced pathways. APExBIO provides NBC19 as a high-purity research tool for dissecting inflammatory signaling and disease mechanisms.

• smRNA-Driven hiPSC Differentiation to Oligodendrocytes: A Ra

  2026-05-20

  The referenced study introduces a synthetic modified mRNA (smRNA) approach for rapidly differentiating human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes (OLs) without viral integration. This method demonstrates high efficiency and safety, holding promise for regenerative medicine and therapeutic cell transplantation.

• Carboxylesterase Interferes with Amplex Red H2O2 Assays

  2026-05-19

  This study reveals that carboxylesterase enzymes can convert Amplex Red to resorufin independently of hydrogen peroxide and horseradish peroxidase, causing substantial interference in mitochondrial H2O2 release assays. These findings urge a critical re-evaluation of prior ROS measurements using the Amplex Red system and provide practical guidance for assay design and data interpretation.

• TaqI Restriction Endonuclease: Rapid, Sequence-Specific DNA

  2026-05-19

  TaqI Restriction Endonuclease (SKU K3053) offers fast and efficient cleavage of plasmid, PCR, or genomic DNA for molecular biology workflows requiring rapid turnaround. It is ideal for applications needing precise sticky-end generation but is not intended for diagnostic or medical use. Researchers should ensure compatibility with their DNA substrates and adhere to workflow guidelines for optimal results.

• 2X HyperFusion High-Fidelity Master Mix for Precision PCR

  2026-05-18

  Unlock ultra-accurate DNA amplification and cloning with 2X HyperFusion High-Fidelity Master Mix. This advanced master mix streamlines high-fidelity PCR workflows, offering robust performance, minimal optimization, and exceptional error rates for cutting-edge applications like CRISPR editing and immunotherapy research.

• Murine RNase Inhibitor: Precision RNA Protection in RT-PCR

  2026-05-18

  Murine RNase Inhibitor from APExBIO redefines RNA stability for sensitive RT-PCR, cDNA synthesis, and in vitro transcription by combining oxidation resistance with selective RNase A inhibition. Its compatibility with low DTT conditions ensures robust RNA degradation prevention, even in challenging workflows. Explore protocol enhancements, troubleshooting, and cross-study innovations to optimize your RNA-based assays.

• AR Heterogeneity and Distinct Therapeutic Responses in Prost

  2026-05-17

  This study uncovers how heterogeneity in androgen receptor (AR) expression among prostate cancer cells drives divergent responses to castration and antiandrogen therapy. The findings reveal molecular mechanisms underlying therapy resistance and suggest new avenues for targeting both AR-high and AR-low prostate cancer cell populations.

635 records 7/43 page Previous Next First page 上5页 678910 下5页 Last page